Patents
Sitemap › C07 - Organic chemistry › C07J - Steroids › C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups
Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
06/2010
06/24/2010US20100160268 Isoflavonoid Analogs and their Metal Conjugates as Anti-Cancer Agents
05/2010
05/25/2010CA2472379C Process for the preparation of 7.alpha.-methylsteroids
05/06/2010US20100113408 21-substituted progesterone derivatives as new antiprogestational agents
04/2010
04/22/2010US20100099141 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds
04/15/2010US20100092386 System for delivering therapeutic agents into living cells and cells nuclei
04/13/2010US7696190 16Alpha-methyl or ethyl substituted estrogens
04/08/2010US20100086583 Lipid-analogous phosphoric triesters
03/2010
03/16/2010US7678781 11-phosphorous steroid derivatives useful as progesterone receptor modulators
03/10/2010EP2160398A2 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS
03/02/2010US7671045 carcinoma and adenocarcinomas of the breast; Type II diabetes mellitus; 19,24-Dinorchola-4,9,20-trien-3-one, 17,23-epoxy-11-[4-(5,5-Dimethyl-2-oxo-2 lambda 5-[1,3,2]dioxaphosphinan-2-yl)-phenyl]-, (11 beta ,17 alpha )-(9Cl)
02/2010
02/25/2010US20100048887 Compounds including an anti-inflammatory pharmacore and methods of use
02/11/2010US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules
02/04/2010US20100029603 16alpha-methyl or ethyl substituted estrogens
01/2010
01/21/2010US20100016563 Water soluble cholesterol derivatives
12/2009
12/30/2009EP1989218B1 17-phosphorous steroid derivatives useful as progesterone receptor modulators
12/30/2009EP1470151B1 Process for the preparation of 7-alpha-methylsteroids
12/17/2009WO2009152171A1 Corticosteroid linked beta-agonist compounds for use in therapy
12/03/2009US20090298175 Steroidal Ligands and Their Use in Gene Switch Modulation
10/2009
10/28/2009CN101568547A Substituted estratrien derivatives as 17beta hsd inhibitors
09/2009
09/22/2009US7592469 Such as cholesteryl-phospho-diglycerol, 1,2-dimyristoyl-sn-glycero-3-phospho-diglycerol; comprise apolar lipid structures; can be used in particular as liposome constituents; long circulation times and accumulate exclusively in the spleen or, particularly importantly, be taken up by tumor cells
09/16/2009EP2099814A1 Substituted estratrien derivatives as 17beta hsd inhibitors
09/08/2009CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents
08/2009
08/19/2009EP2088865A2 Guggulphospholipid methods and compositions
08/05/2009EP2083621A2 Modulators of amyloid-beta production
07/2009
07/29/2009EP2081951A1 Progesterone receptor antagonists
06/2009
06/30/2009US7553830 Compositions for the delivery of negatively charged molecules
06/23/2009CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/18/2009WO2009074313A1 Method for the aromatization of 19-nor-androst-4-en-3-ones into estra-1,3,5(10)-trienes
06/18/2009CA2707597A1 Process for aromatizing 19-norandrost-4-en-3-ones to estra-1,3,5(10)-trienes
06/04/2009WO2008089093A3 Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
05/2009
05/12/2009CA2315829C Angiostatic agents and compositions for controlling ocular hypertension
04/2009
04/29/2009CN101421290A 17-phosphorous steroid derivatives useful as progesterone receptor modulators
04/28/2009CA2416311C 16alpha-methyl or ethyl substituted estrogens
04/22/2009CN101415720A 11-phosphorous steroid derivatives useful as progesterone receptor modulators
04/14/2009CA2192941C Sterol derivatives used for regulation of meiosis
03/2009
03/19/2009WO2009033499A1 Total synthesis of enantiopure desogestrel
03/19/2009WO2009001148A3 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11β-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS
01/2009
01/20/2009CA2304770C A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds
12/2008
12/16/2008CA2327714C Preparation of 4,4-dimethyl-5.alpha.-cholesta-8,14,24-triene-3.beta.-o1 and novel intermediate compounds
11/2008
11/25/2008US7455856 Lipid-derivatized bisphosphonic acid
11/18/2008CA2493704C Platinum complexes containing chemically modified bile acids, having antitumor activity
11/12/2008EP1989218A2 17-phosphorous steroid derivatives useful as progesterone receptor modulators
11/12/2008EP1989217A2 11-phosphorous steroid derivatives useful as progesterone receptor modulators
11/06/2008WO2008067086A3 Compositions and methods for suppressing endometrial proliferation
09/2008
09/24/2008CN100420699C Process for the production of tibolone
08/2008
08/19/2008CA2151801C 3'-modified oligonucleotide derivatives
07/2008
07/24/2008WO2008089093A2 Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
06/2008
06/10/2008CA2259981C 6,7-oxygenated steroids and uses related thereto
06/05/2008WO2008065100A1 Substituted estratrien derivatives as 17beta hsd inhibitors
06/05/2008CA2673128A1 Compositions and methods for suppressing endometrial proliferation
06/05/2008CA2671075A1 Substituted estratrien derivatives as 17beta hsd inhibitors
05/2008
05/22/2008WO2008058767A1 Progesterone receptor antagonists
05/22/2008US20080119443 Certain lithocholic acid analogues that inhibit sialyltransferase
05/22/2008CA2669767A1 Progesterone receptor antagonists
04/2008
04/30/2008EP1916255A2 Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound
04/08/2008CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy
03/2008
03/25/2008US7348320 lower toxicity and higher selectivity
03/11/2008CA2382489C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
03/05/2008CN100372864C Process for the preparation of 7-alpha-methylsteroids
02/2008
02/21/2008US20080044552 Water and/or food-quality, organic solvents used in extraction steps to obtain high content of steroidal glycosides to be used as anorexigenic agents; minimizing heavy metal and/or polyaromatic hydrocarbon content in extracts; by-products of fatty acid and long-chain waxes used in cosmetics
02/13/2008CN100368425C 6,7-oxygenated steroids and uses related thereto
01/2008
01/29/2008CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
01/15/2008CA2123405C Angiostatic steroids
01/03/2008WO2007098381A3 11-phosphorous steroid derivatives useful as progesterone receptor modulators
12/2007
12/12/2007CN100354299C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
11/2007
11/14/2007CN100348609C Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/01/2007WO2007098382A3 17-phosphorous steroid derivatives useful as progesterone receptor modulators
10/2007
10/31/2007EP1178994B1 Improved process for phosphorylation
10/04/2007US20070232570 11-phosphorous steroid derivatives useful as progesterone receptor modulators
09/2007
09/13/2007US20070213310 Prodrugs for Use as Ophthalmic Agents
08/2007
08/30/2007CA2642829A1 11-phosphorous steroid derivatives useful as progesterone receptor modulators
08/30/2007CA2642566A1 17-phosphorous steroid derivatives useful as progesterone receptor modulators
08/08/2007EP0927180B1 Heterocyclic compounds and their use for isolating nucleic acids
08/01/2007EP1556391B1 Lipid-analog phosphoric acid triester
07/2007
07/05/2007US20070154537 Lipid-derivatized bisphosphonic acid
06/2007
06/26/2007US7235650 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis
06/21/2007US20070142306 Strontium-based complexes, pharmaceutical compositions and dietetic products
06/14/2007US20070135390 Phosphate derivatives
06/07/2007US20070129332 Processes to prepare eplerenone
05/2007
05/31/2007US20070123704 7alpha-biscarbonyl-substituted steroid compounds
05/24/2007US20070117780 Process to Prepare Eplerenone
05/23/2007EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof
05/10/2007US20070105826 Novel fusidic acid derivatives
04/2007
04/25/2007EP1599233B1 Sterilization of beclomethasone drug particles for pulmonary delivery
04/19/2007US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
04/17/2007US7205287 Platinum complexes having antitumor activity
02/2007
02/27/2007CA2425849C Angiostatic steroids
02/22/2007US20070042999 Phosphate derivatives of pharmaceutical products
01/2007
01/24/2007EP1682156B1 Strontium-based complexes, pharmaceutical compositions and dietetic products
01/18/2007US20070015927 New phosphoramidite compounds
12/2006
12/07/2006US20060276443 21-substituted progesterone derivatives as new antiprogestational agents
11/2006
11/22/2006EP1724254A2 Novel compositions for the delivery of negatively charged molecules
11/22/2006EP1551860B1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/21/2006CA2295867C Diglycerid and sterol based organometallic complexes and pharmaceutical compositions and dietetic products containing them
11/15/2006CN1863814A Process for the preparation of 7-alpha-methylsteroids
10/2006
10/19/2006US20060235198 Process for obtaining fatty acid alkyl esters, rosin acids and sterols from crude tall oil
10/04/2006EP1706415A1 Lipid- derivatized bisphosphonic acid
09/2006
09/21/2006US20060211857 6,7-Oxygenated steroids and uses related thereto
09/14/2006US20060205697 Novel betulin derivatives, preparation thereof and use thereof
08/2006
08/29/2006CA2212856C Benzopyran-containing compounds and method for their use
1 2 3 4 5 6 7 8 9 10 11 12 ... 16